[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ira Liran, a director of Vita Coco Company, Inc. (COCO), reported the sale of 30,000 shares of common stock on 08/20/2025 under a Rule 10b5-1 trading plan at a weighted average price of $36.08 per share. The filing states the shares were sold in multiple transactions at prices ranging from $36.00 to $36.30 and that the sold shares are held by the Ira Liran 2012 Family Trust.

After the reported transactions the filing discloses beneficial holdings of 782,579 shares indirectly by the Ira Liran 2012 Family Trust and 638,341 shares directly. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Liran and indicates the sale was made pursuant to an established trading plan.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating pre-established trading authorization
• Filing discloses weighted-average price and price range ($36.08 weighted average; $36.00–$36.30 range)
• Clear disclosure of beneficial ownership including indirect trust holdings and direct holdings

Negative

• Director sold 30,000 shares, which some investors may view negatively despite plan-based sale
• Form 4 does not itemize number of shares sold at each separate price; requester must ask issuer or SEC staff for the breakdown

Insights

Securities Analyst

TL;DR: Routine insider sale under a 10b5-1 plan; disclosure is timely and provides weighted-average price and share ranges.

The Form 4 reports a planned sale of 30,000 shares by Director Ira Liran executed under a Rule 10b5-1 trading plan, with a disclosed weighted average price of $36.08 and transaction price range $36.00–$36.30. The filing clarifies ownership split between an individual holding (638,341 shares direct) and the Ira Liran 2012 Family Trust (782,579 shares indirect). This disclosure is standard for Section 16 reporting and allows investors to see the mechanics and scale of the transaction but does not itself change company fundamentals.

Corporate Governance Expert

TL;DR: Governance procedures observed; sale executed under a 10b5-1 plan and attorney-in-fact signature provided.

The Form 4 indicates adherence to governance and insider trading compliance through use of a Rule 10b5-1 plan and a signed filing by an attorney-in-fact. The filing includes an explanation of the weighted-average sale price and commits to provide detailed execution-level pricing on request, which enhances disclosure transparency. This is a routine insider disposition with clear attribution of indirect holdings via the family trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		S(1)		30,000	D	$36.08(2)	782,579	I	by Ira Liran 2012 FT(3)
Common Stock								638,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Ira Liran 2012 Family Trust.

	By: Alison Klein, Attorney-in-Fact For: Ira Liran	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did COCO director Ira Liran report on Form 4?

The Form 4 reports that Ira Liran sold 30,000 shares of Vita Coco Company, Inc. (COCO) on 08/20/2025 under a Rule 10b5-1 plan.

At what price were the COCO shares sold by Ira Liran?

The filing reports a weighted average price of $36.08 and states individual sale prices ranged from $36.00 to $36.30.

How many COCO shares does Ira Liran beneficially own after the sale?

The Form 4 discloses 782,579 shares indirectly638,341 shares directly following the reported transactions.

Was the sale prearranged or part of insider trading rules?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Who signed the Form 4 for Ira Liran?

The Form 4 was signed by Alison Klein, Attorney-in-Fact on behalf of Ira Liran on 08/22/2025.